Farmacy

Aug 18 2017

Keystone Symposia # #keystone #symposia, #keystone #conference, #keystone #conferences, #keystone #meeting, #keystone #meetings, #life #science,


#

Registered Attendees

Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information
  • Login to My Account page

    This meeting took place in 2017

    For a complete list of the meetings for the upcoming/current season, see our meeting list. or search for a meeting.

    Engineered Cells and Tissues as Platforms for Discovery and Therapy (K1)

    Organizer(s) Laura E. Niklason, Milica Radisic and Nenad Bursac

    March 9 12, 2017

    Fairmont Copley Plaza Boston, Massachusetts USA

    Discounted Abstract Deadline: Nov 9, 2016

    Abstract Deadline: Dec 13, 2016

    Scholarship Deadline: Nov 9, 2016

    Discounted Registration Deadline: Jan 13, 2017

    Sponsored by Editas Medicine, Inc. Juno Therapeutics, Merck & Co. Inc. and Thermo Fisher Scientific Inc.

    Summary of Meeting:
    Tissue engineering, cell therapies and regenerative medicine have witnessed accelerated progress over the past decade. Fueled by fundamental discoveries in iPS, progenitor, and developmental cell biology, cells are now used as building blocks to create model systems, as testing platforms for drug interventions and as active therapeutics. High-throughput production of various types of “microtissues” or “organoids” is making increasing contributions to our understanding of human development, disease and repair. This Keystone Symposia meeting will highlight these rapidly emerging cell-based tools for fundamental and applied discovery. Culture systems ranging from simple cell cluster organoids, to highly advanced cell-electronic composites, will be discussed. In addition, the encouraging progress that is being made in cell-based therapies across a range of organs and diseases will be featured. The goal of this meeting is to provide a state-of-the-art review of both pluripotent and differentiated cells as tools for discovery and therapy. A broad range of cell types and therapeutic areas will be included.

    No registration fees are used to fund entertainment or alcohol at this conference

    Conference Program Print | View meeting in 12 hr (am/pm) time

    The meeting will begin on Thursday, March 9 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Sunday, March 12 with a closing plenary session from 17:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Monday, March 13 in order to fully experience the meeting.

    THURSDAY, MARCH 9

    * Laura E. Niklason. Yale University, USA

    Amir Ali Khan. University of Sharjah, United Arab Emirates
    Unravelling the Gene Expression Profiles of the Early Differentiation of Mesenchymal Stem Cells into Neural Lineage

    Sijie Sun. University of Washington, USA
    Bioengineering 3D Human Skin Equivalent with Perfused Microvascular Network to Study Host-Viral Interactions During Infection

    Christopher Hubert. Cleveland Clinic, Lerner Research Institute, USA
    Modeling Glioblastoma through Cancer Stem Cell Organoids

    Anastasia Korolj. University of Toronto, Canada
    Biomimetic Curvature in Cell Culture Platform Improves Podocyte Differentiation in vitro

    Sara Nunes Vasconcelos. University of Toronto, Canada
    Diabetes Impairs Arterio-Venous Specification in Engineered Vascular Tissues in a Perivascular Cell Recruitment-Dependent Manner

    Ryan LaRanger. University of Texas Southwestern Medical Center, USA
    Engineering Reconstituted Decellularized Mouse Lungs with Conditionally Reprogrammed Human Bronchial Epithelial Cells


    Written by admin


    Leave a Reply

    Your email address will not be published. Required fields are marked *